Search - tctmd.com

Displaying 1 - 8 of 8

Sort: Relevancy | Date

Presentation THT 2026

The Effects Of Istaroxime In Patients With Acute Heart Failure (AHF) And Cardiogenic Shock (CS) – Combined Analysis Of 5 Phase 2 Placebo Controlled Clinical Trials

Presenter: Beth A. Davison

March 04, 2026

Presentation THT 2026

LVAD Combined with hiPSC-Cardiomyocyte Transplantation for Advanced Heart Failure: Preliminary Safety and Functional Recovery Results from a Randomized Trial

Presenter: yongfeng Shao

March 03, 2026

News Conference News THT 2025

Positive Results With Carillon Mitral Device Seen in Real-world Registries

Todd Neale

February 21, 2025

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

News Conference News THT 2023

Meta-analysis Hints at Survival Benefit With LAP Monitoring in HFrEF

Shelley Wood

March 22, 2023

News Conference News THT 2023

REDUCE LAP-HF II Subanalysis Makes the Case for Invasive Exercise Tests

Yael L. Maxwell

March 22, 2023

News Conference News THT 2023

Pulmonary Artery Denervation Makes Inroads in PAH Due to Left-Sided HF

Shelley Wood

March 21, 2023

Presentation THT 2023

Long-Term Improvement in Clinical Outcome in Patients With Combined Pre- and Post-Capillary Pulmonary Hypertension: 3-Year Analysis From PADN-5 Trial

Presenter: Dongming Hou

March 21, 2023

Advertisement

The Effects Of Istaroxime In Patients With Acute Heart Failure (AHF) And Cardiogenic Shock (CS) – Combined Analysis Of 5 Phase 2 Placebo Controlled Clinical Trials

LVAD Combined with hiPSC-Cardiomyocyte Transplantation for Advanced Heart Failure: Preliminary Safety and Functional Recovery Results from a Randomized Trial

Positive Results With Carillon Mitral Device Seen in Real-world Registries

Debating the Role of T-TEER in the Sickest Patients

Meta-analysis Hints at Survival Benefit With LAP Monitoring in HFrEF

REDUCE LAP-HF II Subanalysis Makes the Case for Invasive Exercise Tests

Pulmonary Artery Denervation Makes Inroads in PAH Due to Left-Sided HF

Long-Term Improvement in Clinical Outcome in Patients With Combined Pre- and Post-Capillary Pulmonary Hypertension: 3-Year Analysis From PADN-5 Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content